JP2022536797A5 - - Google Patents

Info

Publication number
JP2022536797A5
JP2022536797A5 JP2021574932A JP2021574932A JP2022536797A5 JP 2022536797 A5 JP2022536797 A5 JP 2022536797A5 JP 2021574932 A JP2021574932 A JP 2021574932A JP 2021574932 A JP2021574932 A JP 2021574932A JP 2022536797 A5 JP2022536797 A5 JP 2022536797A5
Authority
JP
Japan
Prior art keywords
body weight
seq
average body
par1
par3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574932A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536797A (ja
JP7818405B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038036 external-priority patent/WO2020257221A1/en
Publication of JP2022536797A publication Critical patent/JP2022536797A/ja
Publication of JP2022536797A5 publication Critical patent/JP2022536797A5/ja
Priority to JP2025133519A priority Critical patent/JP2025172264A/ja
Application granted granted Critical
Publication of JP7818405B2 publication Critical patent/JP7818405B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021574932A 2019-06-18 2020-06-17 炎症性状態を処置するための方法および組成物 Active JP7818405B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025133519A JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862977P 2019-06-18 2019-06-18
US62/862,977 2019-06-18
PCT/US2020/038036 WO2020257221A1 (en) 2019-06-18 2020-06-17 Methods and compositions for treating inflammatory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025133519A Division JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2022536797A JP2022536797A (ja) 2022-08-18
JP2022536797A5 true JP2022536797A5 (https=) 2023-11-30
JP7818405B2 JP7818405B2 (ja) 2026-02-20

Family

ID=74040112

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021574932A Active JP7818405B2 (ja) 2019-06-18 2020-06-17 炎症性状態を処置するための方法および組成物
JP2025133519A Withdrawn JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025133519A Withdrawn JP2025172264A (ja) 2019-06-18 2025-08-08 炎症性状態を処置するための方法および組成物

Country Status (6)

Country Link
US (1) US20220313780A1 (https=)
EP (2) EP3986560A4 (https=)
JP (2) JP7818405B2 (https=)
CN (1) CN114258317B (https=)
AU (1) AU2020295989A1 (https=)
WO (1) WO2020257221A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120518705A (zh) * 2025-07-23 2025-08-22 中国海洋大学 一种多肽类化合物及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965343A (en) 1988-01-28 1990-10-23 Hoffmann-La Roche Inc. Method of peptide synthesis
US5849954A (en) 1996-01-18 1998-12-15 Research Corporation Technologies, Inc. Method of peptide synthesis
US5892014A (en) * 1996-10-30 1999-04-06 The Regents Of The University Of California DNA encoding a protease-activated receptor 3
CN1308671A (zh) * 1998-05-05 2001-08-15 科里克萨公司 髓磷脂碱性蛋白肽及其应用
IL147031A0 (en) 1999-08-02 2002-08-14 Synt Em Sa Computational design methods for making molecular mimetics
WO2001057183A2 (en) 2000-02-04 2001-08-09 New England Biolabs, Inc. Method for producing circular or multimeric protein species in vivo or in vitro and related methods
ATE516497T1 (de) * 2000-03-06 2011-07-15 Asterand Acquisition Llc Screening für funktionshomologien
US7696168B2 (en) * 2000-04-21 2010-04-13 Tufts Medical Center, Inc. G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
FR2841559A1 (fr) * 2002-06-28 2004-01-02 Pfizer Recepteurs par modifies, preparation et utilisations
GB0224013D0 (en) * 2002-10-15 2002-11-27 Oxford Glycosciences Uk Ltd A protein involved in therapy
WO2004056309A2 (en) * 2002-12-05 2004-07-08 Socratech L.L.C. Neuroprotective activity of activated protein c is independent of its anticoagulant activity
CA2604180A1 (en) 2005-04-29 2006-11-09 (Osi) Eyetech, Inc. Vegf variants
US20080090760A2 (en) 2005-12-09 2008-04-17 Todd Hembrough Compositions and Methods for Inhibiting Cellular Proliferation
CN101801462A (zh) * 2007-07-13 2010-08-11 健泰科生物技术公司 用于癌症、炎性病症和自身免疫性病症的治疗和诊断
WO2013070256A2 (en) * 2011-11-07 2013-05-16 The Scripps Research Institute Protease activated receptor-1 (par1) derived cytoprotective polypeptides and related methods
EP2870170B1 (en) * 2012-07-03 2017-09-06 Il Yang Pharm. Co., Ltd. Novel peptides and use thereof
US11306130B2 (en) * 2016-04-01 2022-04-19 Arizona Board Of Regents On Behalf Of The University Of Arizona PAR3 mimetic peptides and uses thereof
WO2019051565A1 (en) * 2017-09-18 2019-03-21 BH Biotech Pty Ltd COMPOSITION AND USES

Similar Documents

Publication Publication Date Title
US5840305A (en) Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity
JP4006021B2 (ja) ケモカインの生物学的活性の強化法
EP1849478A2 (en) Inflammatory mediator antagonists
ES2380950T3 (es) Uso de la proteinasa IdeS ( de S, pyogenes) para tratar enfermedades autoinmunitarias y rechazo de injerto
UA85531C2 (uk) Застосування il-18 інгібіторів для лікування або попередження пов'язаної з сепсисом дисфункції серця
CN102665754A (zh) 衍生自il-2的免疫调节多肽及其在治疗癌症和慢性感染中的用途
JPH0372430A (ja) 細胞間粘着分子の官能性誘導体を用いた抗ウィルス剤
EP0647272B1 (en) Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof
CN116615221A (zh) 用于治疗细胞因子释放综合征和细胞因子风暴相关病症的靶向il-2、il-9和il-15信号传导的拮抗肽
KR20210091032A (ko) 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체의 지속형 결합체의 폐질환의 치료 용도
US6664374B1 (en) Polypeptides comprising IL-6 ligand-binding receptor domains
JP2022536797A5 (https=)
JPH09512168A (ja) 敗血症の治療用ヘパリン結合タンパク質およびその製造方法
JP2004510426A (ja) 多発性硬化症の治療におけるケモカイン変異体
US6709649B1 (en) RANTES derived peptides with anti-HIV activity
WO1998033067A1 (en) Transcription factors that repress hiv transcription and methods based thereon
AU723905B2 (en) Treatment of HIV-infection by interfering with host cell cyclophilin receptor activity
WO1997011966A1 (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
US7608691B2 (en) Antibodies against IL-16 antagonist peptides
ES2222625T3 (es) Peptido t y peptidos asociados destinados al tratamiento de la inflamacion incluyendo la esclerosis multiple.
US7494975B2 (en) Anti-HIV composition, production method thereof and medicament
CN110139659B (zh) 用于治疗干燥综合征的肽
AU672749B2 (en) An anti-HIV protein, TAP 29, from trichosanthes, DNA coding therefor and therapeutic uses thereof
AU763900B2 (en) Treatment of HIV-infection by interfering with host cell cyclophilin receptor activity
JP4427270B2 (ja) 慢性肺疾患治療剤